Codexis (CDXS) Interest Coverage Ratio (QoQ) (2010 - 2026)
Codexis (CDXS) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.09% |
| Mar 31, 2026 | -101.71% |
| Dec 31, 2025 | 2,357.62% |
| Sep 30, 2025 | -52.22% |
| Jun 30, 2025 | 98.00% |
| Mar 31, 2025 | -173.75% |
| Dec 31, 2024 | 62.58% |
| Sep 30, 2024 | 27.16% |
| Jun 30, 2024 | -124.30% |
| Mar 31, 2024 | -15,352.54% |
| Dec 31, 2023 | 101.17% |
| Sep 30, 2023 | -2,073.51% |
| Jun 30, 2023 | 97.93% |
| Mar 31, 2023 | -75.38% |
| Dec 31, 2022 | -213.19% |
| Sep 30, 2022 | -4,812.08% |
| Jun 30, 2022 | 99.43% |
| Mar 31, 2022 | -231.14% |
| Dec 31, 2021 | -5,343.89% |
| Sep 30, 2021 | 130.76% |